How many studies have been conducted on Insulin Glargine?

BiohacksAI has indexed 297 PubMed studies on Insulin Glargine, including 77 randomized controlled trials (RCTs). 74% of studies involve human subjects.

What are the main research areas for Insulin Glargine?

The primary research domains for Insulin Glargine are 🧬 Hormones, 🔥 Metabolic, 🔬 Oncology. This is based on analysis of 297 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Insulin Glargine

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

297+ PubMed studies analyzed · 77 RCTs · Evidence Score: 59

Research Domains

Insulin Glargine has been studied across 7 research domains including 🧬 Hormones, 🔥 Metabolic, 🔬 Oncology, 😴 Sleep, 🫁 Liver & Detox. The primary research focus is 🧬 Hormones with 99% of studies addressing this area.

Loading evidence profile...

This evidence profile for Insulin Glargine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.